Device Therapy in Heart Failure
Heart failure affects over 5 million patients in the United States alone, and is a chronic and debilitating disease. While a number of pharmacologic therapies have shown varying degrees of effectiveness, many recent advances in the treatment of heart failure has focused on device based therapies. In...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press,
2009.
|
| Σειρά: | Contemporary Cardiology
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Pathophysiology of Heart Failure
- Medical Therapy for Heart Failure
- Device Trials in Chronic Heart Failure: Implications of Trial Design
- The FDA Perspective on Heart Failure Devices
- Hemodynamic Monitoring in Heart Failure
- Implantable Cardioverter-Defibrillators
- Cardiac Resynchronization Therapy
- Pacing and Defibrillation for Atrial Arrhythmias
- Atrial Fibrillation Ablation
- Percutaneous Treatment of Coronary Artery Disease
- Percutaneous Management of Peripheral Arterial Disease
- Percutaneous Management of Valvular Heart Disease
- Ventricular Assist Devices and Total Artificial Hearts
- Device Therapy for Left Ventricular Dysfunction.
